Work

CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice

Year: 2017
Type: article
Abstract: mice following Cpf1-mediated germline editing. These findings are the first to show the efficiency of Cpf1-mediated correction of genetic mutations in human cells and an animal disease model and represent a significant step toward therapeutic translation of gene editing for correction of DMD.
Language: English
Open Access status: gold
Estimated APC paid: $4,500
OpenAlex ID: W2607120679
FWCI: 10.94
Cites: 32
Cited by: 235
Related to: 10